Serum and blood based biomarkers for lung cancer screening: a systematic review

Abstract Background Lung cancer is the second most common cancer and the leading cause of cancer death for both men and women. Although low-dose CT (LDCT) is recommended for lung cancer screening in high-risk populations and may decrease lung cancer mortality, there is a need to improve the accuracy...

Full description

Bibliographic Details
Main Authors: Gavin C. W. Chu, Kim Lazare, Frank Sullivan
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4024-3